Penumbra, Inc. (PEN)
NYSE: PEN · Surgical & Medical Instruments & Apparatus · Alameda, CA · filing with the SEC since 2005
Grade7.0
◀ Past 6.6● Present 8.0▶ Future 6.0
Who owns Penumbra, Inc.
As filed with the SECHolders of 5% or more
2
Barclays PLC holds 5.95% of COMMON-STOCK, as its SCHEDULE 13G filed Aug 13, 2026 says.
Directors and officers
11
report now, of 19 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Barclays PLC
SCHEDULE 13G · filed Aug 13, 2026 · COMMON-STOCK
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Fmr LLC
SCHEDULE 13G/A · filed Feb 6, 2026 · COMMON STOCK · reported falling below 5%, from 13% in Feb 5, 2026
T. Rowe Price Associates, Inc.
SCHEDULE 13G/A · filed Feb 14, 2025 · COMMON STOCK · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What PEN reports owning in othersstakes of 5% or more, and other ties
15 subsidiaries in 15 countries, from the list filed with the 10-K filed Feb 25, 2026.
Insider tradesForm 4
32sales
0purchases
32sales on a scheduled plan
5people selling
$11.1Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 16, 2025 to Oct 16, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 16, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 19 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bose Arani | Chief Innovator | 10 | $9.1M | 10 | 0 | $0 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | 16 | $1.0M | 16 | 0 | $0 |
| Yuen Maggie | Chief Financial Officer | 1 | $800,000 | 1 | 0 | $0 |
| Grewal Harpreet | director | 4 | $200,000 | 4 | 0 | $0 |
| Wilder Thomas | director | 1 | $100,000 | 1 | 0 | $0 |